Great news! According to Race Oncology, 95% of applications need minor changes or additional information, it’s fantastic that PAR is among the 5% that pass on the first attempt.
Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.3¢ |
Change
-0.008(2.59%) |
Mkt cap ! $110.9M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 28.3¢ | $21.81K | 76.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 295633 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 75453 | 6 |
View Market Depth
| Last trade - 12.48pm 17/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |